跳至主要内容
临床试验/TCTR20190909001
TCTR20190909001招募中3 期

Rate of recurrent neutropenia between the omitted of bolus dose of fluorouracil group compare with the oxaliplatin dose reduction group in colorectal cancer patients, a randomized cross-over trial

-0 个研究点目标入组 42 人开始时间: 2019年9月9日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 90 Years(—)
性别
All

入选标准

  • 1. An age is greater than or equal to 18
  • 2. histologically confirmed AJCC/UICC stage III or IV adenocarcinoma colon cancer
  • 3. histologically confirmed AJCC/UICC stage IV adenocarcinoma rectal cancer
  • 4. history of neutropenia (absolute neutrophils count < 1,500) from previous chemotherapy (FOLFOX4 or FOLFOL6 regimen)
  • 5. adequate organ function
  • 6. ECOG performance status 0 to 1
  • 7. signed written informed consent obtained prior to any study specific procedures

排除标准

  • 1. eGFR less than 15
  • 2. abnormal liver function test
  • 3. other malignancies within the last 5 years
  • 4. history of clinically relevant psychritic disability
  • 5. previous radiotherapy within the last 6 months

研究者

发起方
&#45;

相似试验